Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voluven vs Tetraspan in Major Urological Procedures
NCT01670604Phase 4Unknown
- Sponsor
- Kasr Al Ainy Hospital
- Start
- Jan 2012
- Primary completion
- Mar 2013
- Modality
- Polymer-based Nanoparticles, Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Volulyte, hydroxyethyl starch 130/0.42 in hypovolemia, sponsored by Kasr Al Ainy Hospital. Status: unknown.
02
Drugs
Volulytehydroxyethyl starch 130/0.42
03
Conditions
hypovolemia
Beyond the preview
Go deeper on NCT01670604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01670604.